Halozyme Therapeutics Inc. (HALO)
BMV
Real-time Data
02:30 PM
Day's Range
1,968.6952 wk Range
1,121.86Profile - HALO - Halozyme Therapeutics Inc.
Profile
Mic Code
XMEX
Sector
Healthcare
Industry
Biotechnology
Employees
423
Halozyme Therapeutics Inc. is a biopharmaceutical technology company focused on drug delivery solutions and specialty medicines. Its core platform, ENHANZE, uses the proprietary enzyme rHuPH20 to help enable subcutaneous delivery of injectable therapies and fluids, supporting more convenient administration and improved patient comfort. The company also develops, manufactures, and commercializes drug-device combination products with advanced auto-injector technology for use in areas such as oncology and other specialty therapeutic settings. In addition to its platform business, Halozyme Therapeutics Inc. markets proprietary products including Hylenex and XYOSTED, and works with pharmaceutical partners to support a range of commercial and development-stage programs. Headquartered in San Diego, California, Halozyme Therapeutics Inc. plays a specialized role in the biopharmaceutical market by providing technologies that help improve how existing medicines are delivered and used.
Profile Details
Type
Common Stock
Address
12390 El Camino Real
City
San Diego
State
CA
Zip
92130
Country
United States
Phone
858 794 8889
Key Executives - HALO - Halozyme Therapeutics Inc.
Key executives
Cross Listings - HALO - Halozyme Therapeutics Inc.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
